EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Meng Tao, Jing Han, Juanyi Shi, Hao Liao, Kai Wen iD, Weidong Wang iD, Sintim Mui iD, Huoming Li, Yongcong Yan, Zhiyu Xiao

Journal of Hepatocellular Carcinoma · 2023-07 · Volume 10 · 1069-1083

DOI: 10.2147/jhc.s411806 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Hepatocellular Carcinoma, 2023-07. Verfasst von Meng Tao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

applicationdrug resistancehepatocellular carcinomalenvatinib

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
  • Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, People's Republic of China.

ORCID-Profile: Kai Wen, Weidong Wang, Sintim Mui

Zitieren

APA

Tao, M., Han, J., Shi, J., Liao, H., Wen, K., Wang, W., Mui, S., Li, H., Yan, Y., & Xiao, Z. (2023). Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 10, 1069-1083. https://doi.org/10.2147/jhc.s411806

Vancouver

Tao M, Han J, Shi J, Liao H, Wen K, Wang W, et al. Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2023;Volume 10:1069-1083. doi:10.2147/jhc.s411806

BibTeX
@article{Tao2023,
  author = {Tao, Meng and Han, Jing and Shi, Juanyi and Liao, Hao and Wen, Kai and Wang, Weidong and Mui, Sintim and Li, Huoming and Yan, Yongcong and Xiao, Zhiyu},
  title = {Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2023},
  volume = {Volume 10},
  pages = {1069--1083},
  doi = {10.2147/jhc.s411806}
}
Kostenlos starten →